ACN - 101321555 Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Resource Library

Research Ethics MonthlyAbout Us

ResourcesProtection for participants

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Journals retract more than a dozen studies from China that may have used executed prisoners’ organs – Retraction Watch (Ivan Oransky | August 2017)0

Posted by Admin in on August 15, 2019
 

In the past month, PLOS ONE and Transplantation have retracted fifteen studies by authors in China because of suspicions that the authors may have used organs from executed prisoners.

All of the original studies — seven in Transplantation, and eight in PLOS ONE — were published between 2008 and 2014. Two involved kidney transplants, and the rest involved liver transplants. Two other journals, the Clinical Journal of the American Society of Nephrology and Kidney International, have recently issued expressions of concern for the same reason.

In an editorial explaining the seven retractions from its journal, the editors of Transplantation write:

Read the rest of this discussion piece

Long-Term Agreement for Services (LTAS) for the Provision of Global Research Quality Assurance Services and an Ethical Review Facility for Evidence Generation (Request for proposal | August 2019)0

Posted by Admin in on August 13, 2019
 

UNICEF is putting out a call for tenders for a Global Ethical Review Facility for the organisation. This would entail undertaking ethical reviews of evidence generation projects across the organization and providing advice on possible mitigation strategies.

Information can be found here: https://www.ungm.org/public/Notice/95212

Gabrielle Berman, PhD
Senior Advisor – Ethics in Evidence Generation
UNICEF Innocenti
Via degli Alfani, 58
Firenze, Italia
50122
Skype: gabrielle.berman

China approves ethics advisory group after CRISPR-babies scandal – Nature (Hepeng Jia | August 2019)0

Posted by Admin in on August 10, 2019
 

Bioethicists hope a national committee will help close loopholes in the country’s biomedical ethics regulations.

China will establish a national committee to advise the government on research-ethics regulations. The decision comes less than a year after a Chinese scientist sparked an international outcry over claims that he had created the world’s first genome-edited babies.

The country’s most powerful policymaking body, the Central Comprehensively Deepening Reforms Commission of the ruling Chinese Communist Party, headed by President Xi Jinping, approved at the end of last month a plan to form the committee. According to Chinese media, it will strengthen the coordination and implementation of a comprehensive and consistent system of ethics governance for science and technology.

The government has released few details on how the committee will work. But Qiu Renzong, a bioethicist at the Chinese Academy of Social Science in Beijing, says it could help to reduce the fragmentation in biomedical ethics regulations across ministries, identifying loopholes in the enforcement of regulations and advise the government on appropriate punishments for those who violate the rules.

Read the rest of this news story

Participants’ Understanding of Informed Consent for Biobanking: A Systematic Review (Papers: Elizabeth R. Eisenhauer, et al | 2017)0

Posted by Admin in on August 7, 2019
 

Abstract
Nurses are increasingly asked to obtain consent from participants for biobanking studies. Biobanking has added unique complexities to informed consent. The purpose of this systematic review was to evaluate participants’ level of understanding of the information presented during the informed consent process unique to the donation of biological specimens for research. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were utilized to conduct the review. PubMed, EMBASE, CINAHL, PsycINFO, Scopus, Web of Science, and ProQuest bibliographic databases were searched. Results indicated that elements of informed consent unique to biobanking were poorly understood. Most studies had authors or funding associated with a biobank. Only one study disclosed and assessed participants’ understanding of moral risks. Increased disclosures, values-clarification, and presenting information via multiple modalities may facilitate understanding. There is a need to improve the quality of informed consent for biobanking studies by utilizing standardized instruments, definitions, and encouraging research about informed choice outside the biobanking industry.

Keywords
biological specimen banks, biobanking, informed consent, moral risks, understanding

Eisenhauer, E. R., Tait, A. R., Rieh, S., Y. & Arslanian-Engoren, C., M. (2017) Participants’ understanding of informed consent for biobanking: a systematic review. Clinical Nursing Research. 28(1) pp30-51
Publisher: https://journals.sagepub.com/doi/10.1177/1054773817722690

0